MedTrace Logo

Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

NCT00690313 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-08-07

No results posted yet for this study

Summary

Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage.

In this study we compare the efficacy of Vigamox eye drops (antibiotic)starting 3 days prior to the injection versus 1 day prior to intravitreal injection.

Conditions

  • Intravitreal Injection Patients

Interventions

DRUG

Vigamox

eye drops 3 times day either 1 or 3 days prior to intravitreal injection

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Illinois Retina Associates

    lead OTHER

Principal Investigators

  • Kourous A Rezaei, MD · Illinois Retina Associates SC

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00690313 on ClinicalTrials.gov